Molecular Endocrinology, Vol 10, 1178-1190, Copyright © 1996 by Endocrine Society

ARTICLES

Determinants of promoter-specific activity by glucocorticoid receptor

EC Guido, EO Delorme, DL Clemm, RB Stein, J Rosen and JN Miner
Ligand Pharmaceuticals, Transcription Research Department, San Diego, California 92121, USA.

Glucocorticoid receptor (GR) is expressed at essentially equal levels in almost all tissues and cell types. Remarkably, glucocorticoids themselves regulate transcription in vivo in both a promoter- and tissue-specific manner. Thus, specific systems must be in place to regulate receptor action within certain cells and at certain promoters. To address two specific aspects of these systems, we have analyzed promoter-specific activity of GR using two different, well studied promoters (termed simple and composite promoters) from which GR activates transcription. The simple promoter depends only on the receptor for glucocorticoid-responsive transcriptional activation, while GR activity at the composite promoter depends on additional transcription factors. We have compared the action of several GR ligands at these promoters and demonstrate fundamental differences in the activities of these ligands on receptor activity. Furthermore, these compounds induce unique conformational changes in receptor, resulting in promoter-specific receptor function. We have identified critical amino acid residues within GR which, when mutated, genetically distinguish the action of GR at these promoters. Taken together, the data indicate that the presence of only the receptor and the ligand is not sufficient to allow activation of transcription. An additional system of regulation influences receptor action in both a tissue- and promoter-selective fashion, suggesting that multiple, regulated surfaces of the receptor respond to the cellular environment and determine the spectrum of GR activities. These functional surfaces may be induced or regulated by ligand binding, by the DNA sequence to which receptor is bound, or by the nonreceptor factors resident at the promoter or in the tissue.

This article has been cited by other articles:

				M. H. Hong, H. Sun, C. H. Jin, M. Chapman, J. Hu, W. Chang, K. Burnett, J. Rosen, A. Negro-Vilar, and J. N. Miner Cell-Specific Activation of the Human Skeletal {alpha}-Actin by Androgens Endocrinology, March 1, 2008; 149(3): 1103 - 1112. [Abstract] [Full Text] [PDF]

				J. Rosen and J. N. Miner The Search for Safer Glucocorticoid Receptor Ligands Endocr. Rev., May 1, 2005; 26(3): 452 - 464. [Abstract] [Full Text] [PDF]

				I. MANOLI, M. U. DE MARTINO, T. KINO, and S. ALESCI Modulatory Effects of l-Carnitine on Glucocorticoid Receptor Activity Ann. N.Y. Acad. Sci., November 1, 2004; 1033(1): 147 - 157. [Abstract] [Full Text] [PDF]

				E. F.C. van Rossum and S. W.J. Lamberts Polymorphisms in the Glucocorticoid Receptor Gene and Their Associations with Metabolic Parameters and Body Composition Recent Prog. Horm. Res., January 1, 2004; 59(1): 333 - 357. [Abstract] [Full Text]

				M. J. Coghlan, P. B. Jacobson, B. Lane, M. Nakane, C. W. Lin, S. W. Elmore, P. R. Kym, J. R. Luly, G. W. Carter, R. Turner, et al. A Novel Antiinflammatory Maintains Glucocorticoid Efficacy with Reduced Side Effects Mol. Endocrinol., May 1, 2003; 17(5): 860 - 869. [Abstract] [Full Text] [PDF]

				J. P. Berger, A. E. Petro, K. L. Macnaul, L. J. Kelly, B. B. Zhang, K. Richards, A. Elbrecht, B. A. Johnson, G. Zhou, T. W. Doebber, et al. Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein {gamma} Selective Modulator Mol. Endocrinol., April 1, 2003; 17(4): 662 - 676. [Abstract] [Full Text] [PDF]

				J. N. Miner, C. Tyree, J. Hu, E. Berger, K. Marschke, M. Nakane, M. J. Coghlan, D. Clemm, B. Lane, and J. Rosen A Nonsteroidal Glucocorticoid Receptor Antagonist Mol. Endocrinol., January 1, 2003; 17(1): 117 - 127. [Abstract] [Full Text] [PDF]

				C. W. Lin, M. Nakane, M. Stashko, D. Falls, J. Kuk, L. Miller, R. Huang, C. Tyree, J. N. Miner, J. Rosen, et al. trans-Activation and Repression Properties of the Novel Nonsteroid Glucocorticoid Receptor Ligand 2,5-Dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and Its Four Stereoisomers Mol. Pharmacol., August 1, 2002; 62(2): 297 - 303. [Abstract] [Full Text] [PDF]

				J. Chen, S. Kaul, and S. S. Simons Jr. Structure/Activity Elements of the Multifunctional Protein, GMEB-1. CHARACTERIZATION OF DOMAINS RELEVANT FOR THE MODULATION OF GLUCOCORTICOID RECEPTOR TRANSACTIVATION PROPERTIES J. Biol. Chem., June 7, 2002; 277(24): 22053 - 22062. [Abstract] [Full Text] [PDF]

				S. Kaul, J. A. Blackford Jr., S. Cho, and S. S. Simons Jr. Ubc9 Is a Novel Modulator of the Induction Properties of Glucocorticoid Receptors J. Biol. Chem., April 5, 2002; 277(15): 12541 - 12549. [Abstract] [Full Text] [PDF]

				S. H. Jho, N. Radoja, M. J. Im, and M. Tomic-Canic Negative Response Elements in Keratin Genes Mediate Transcriptional Repression and the Cross-talk among Nuclear Receptors J. Biol. Chem., November 30, 2001; 276(49): 45914 - 45920. [Abstract] [Full Text] [PDF]

				S. Kaul, J. A. Blackford Jr., J. Chen, V. V. Ogryzko, and S. S. Simons Jr. Properties of the Glucocorticoid Modulatory Element Binding Proteins GMEB-1 and -2: Potential New Modifiers of Glucocorticoid Receptor Transactivation and Members of the Family of KDWK Proteins Mol. Endocrinol., July 1, 2000; 14(7): 1010 - 1027. [Abstract] [Full Text]

				D. Knutti, A. Kaul, and A. Kralli A Tissue-Specific Coactivator of Steroid Receptors, Identified in a Functional Genetic Screen Mol. Cell. Biol., April 1, 2000; 20(7): 2411 - 2422. [Abstract] [Full Text]

				M. M. Montano, A. K. Jaiswal, and B. S. Katzenellenbogen Transcriptional Regulation of the Human Quinone Reductase Gene by Antiestrogen-liganded Estrogen Receptor-alpha and Estrogen Receptor-beta J. Biol. Chem., September 25, 1998; 273(39): 25443 - 25449. [Abstract] [Full Text] [PDF]

				N. B. Sweezey, F. Ghibu, S. Gagnon, E. Schotman, and Q. Hamid Glucocorticoid receptor mRNA and protein in fetal rat lung in vivo: modulation by glucocorticoid and androgen Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L103 - L109. [Abstract] [Full Text] [PDF]

				K. J. Modarress, J. Opoku, M. Xu, N. J. Sarlis, and S. S. Simons Jr. Steroid-induced Conformational Changes at Ends of the Hormone-binding Domain in the Rat Glucocorticoid Receptor Are Independent of Agonist Versus Antagonist Activity J. Biol. Chem., September 19, 1997; 272(38): 23986 - 23994. [Abstract] [Full Text] [PDF]

				S. Chen, N. J. Sarlis, and S. S. Simons Jr. Evidence for a Common Step in Three Different Processes for Modulating the Kinetic Properties of Glucocorticoid Receptor-induced Gene Transcription J. Biol. Chem., September 22, 2000; 275(39): 30106 - 30117. [Abstract] [Full Text] [PDF]

				S. Pandit, W. Geissler, G. Harris, and A. Sitlani Allosteric Effects of Dexamethasone and RU486 on Glucocorticoid Receptor-DNA Interactions J. Biol. Chem., January 4, 2002; 277(2): 1538 - 1543. [Abstract] [Full Text] [PDF]